BMYMP News and Press, Bristol-Myers Squibb $2Pr From 10/30/22

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...

Bristol-Myers Squibb Co (BMY) Q3 2022 Earnings Conference Call October 26, 2022, 08:00 ET Company Participants Timothy Power - VP & Head, IR Giovanni Caforio - Chairman & CEO David Elkins - EVP & CFO Christopher Boerner - EVP & Chief Commercia...

Summary A "patent cliff" is a term used to describe the short period of time when a drug loses its patent protection, thereby affecting the company's revenue. Bristol Myers Squibb faces an enormous amount of patent cliffs, but it has built a wide oncology pipeline that will help i...

Summary Akero recently presented data which did not follow an intent-to-treat (ITT) analysis. They admitted this would have made them miss at least one endpoint. The company twice now has not let investors see all the data from its clinical studies. There are other issues with...

Summary Today is a great time to invest for the long run, though the market may very likely experience more volatility before once again resuming its march higher. We expect meaningful market share gains from most if not all of our investments. Returns from here will be powere...

Summary During August my passive income was up by 2.90% y/y. During September my passive income was up by 41.14% y/y. I made 40 trades during these two months; 38 buys and 2 sales. Another two months, another two steps towards financial freedom! Sorry for the delay h...

Summary Releasing two top October stocks from the long-term Growth and Dividend Breakout portfolio and ten top samples from prior portfolios. The October 2021 portfolio for 1 year is down -4.01% and the October 2020 2-year portfolio is up +3.65% not including additional minimum 2%...

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...

Summary In this article, I explain how I generate ideas and my methodology of adding companies to my watchlist. I also discuss certain areas of my watchlist, including merger arbitrage, semiconductor equipment, and defense contractors. I showcase my entire watchlist and discus...

Summary Ariel Investments’ 13F portfolio value decreased from $11.27B to $10.02B this quarter. They increased Gentex, Resideo Technologies, and Boyd Gaming while reducing Adtalem Global Education, J. M. Smucker, Aflac, and Trip.com. The top three positions are Baidu, Ph...